Author: Lehmann, Kathleen C.; Gorbalenya, Alexander E.; Snijder, Eric J.; Posthuma, Clara C.
Title: Arterivirus RNA-dependent RNA polymerase: Vital enzymatic activity remains elusive Cord-id: xzw8iwzf Document date: 2015_10_23
ID: xzw8iwzf
Snippet: All RNA viruses encode an RNA-dependent RNA polymerase (RdRp), which in arteriviruses is expressed as the C-terminal domain of nonstructural protein 9 (nsp9). Previously, potent primer-dependent RdRp activity has been demonstrated for the homologous polymerase subunit (nsp12) of the distantly related coronaviruses. The only previous study focusing on the in vitro activity of nsp9 of an arterivirus (equine arteritis virus; EAV) reported weak de novo polymerase activity on homopolymeric RNA templa
Document: All RNA viruses encode an RNA-dependent RNA polymerase (RdRp), which in arteriviruses is expressed as the C-terminal domain of nonstructural protein 9 (nsp9). Previously, potent primer-dependent RdRp activity has been demonstrated for the homologous polymerase subunit (nsp12) of the distantly related coronaviruses. The only previous study focusing on the in vitro activity of nsp9 of an arterivirus (equine arteritis virus; EAV) reported weak de novo polymerase activity on homopolymeric RNA templates. However, this activity was not retained when Mn(2+) ions were omitted from the assay or when biologically relevant templates were supplied, which prompted us to revisit the biochemical properties of this polymerase. Based on the properties of active-site mutants, we conclude that the RNA-synthesizing activities observed in de novo and primer-dependent polymerase and terminal transferase assays cannot be attributed to recombinant EAV nsp9-RdRp. Our results illustrate the potential pitfalls of characterizing polymerases using highly sensitive biochemical assays.
Search related documents:
Co phrase search for related documents- acid template and active site residue: 1
- acid template and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
- active site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- active site and additional co: 1, 2
- active site and additional polymerase: 1
- active site and additional protein: 1, 2, 3
- active site and low activity: 1, 2, 3, 4, 5
- active site and low concentration: 1, 2
- active site mutant and acute sars cov respiratory syndrome coronavirus: 1, 2, 3
- active site residue and acute sars cov respiratory syndrome coronavirus: 1
- activity abolish and acute sars cov respiratory syndrome coronavirus: 1
- activity abolish and low activity: 1
- activity display and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7
- activity display and low activity: 1, 2, 3
- activity gain and acute sars cov respiratory syndrome coronavirus: 1
- activity gain and low activity: 1, 2, 3, 4, 5
- activity gain and low activity enzyme: 1
- activity responsible and acute sars cov respiratory syndrome coronavirus: 1, 2
- activity responsible and low activity: 1
Co phrase search for related documents, hyperlinks ordered by date